Company · CIK 0001649094 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Vaxcyte, Inc. · PCVX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 FForm 4 → | Sep 9, 5:56 pm EDT | Grant PickeringCHIEF EXECUTIVE OFFICER, Director | 17,056 | $60.36 | $1,029,500 | 429,902 | — | |
| Sep 8, 2026 FForm 4 → | Sep 9, 5:54 pm EDT | Andrew GuggenhimePRESIDENT AND CFO | 7,155 | $60.36 | $431,876 | 95,316 | — | |
| Sep 8, 2026 FForm 4 → | Sep 9, 5:53 pm EDT | Harpreet S. DhaliwalChief Technical Ops Officer | 7,651 | $60.36 | $461,814 | 68,085 | — | |
| Sep 8, 2026 FForm 4 → | Sep 9, 5:52 pm EDT | Elvia CowanSVP, Finance & CAO | 1,327 | $60.36 | $80,098 | 27,860 | — | |
| Sep 8, 2026 FForm 4 → | Sep 9, 5:46 pm EDT | Jim WassilEVP, Chief Scientific Ofc, COO | 5,459 | $60.36 | $329,505 | 146,769 | — | |
| Sep 4, 2026 SForm 4 → | Sep 9, 5:46 pm EDT | Jim WassilEVP, Chief Scientific Ofc, COO | 2,715 | $60.35 | $163,863 | 145,435 | −1.83% | |
| Sep 4, 2026 AForm 4 → | Sep 9, 5:40 pm EDT | Luis JodarChief Medical Officer | 52,632 | — | — | 52,632 | — | |
| Sep 1, 2026 SForm 4 → | Sep 2, 7:58 pm EDT | Jim WassilCHIEF OPERATING OFFICER | 3,477 | $61.07 | $212,352 | 155,041 | −2.19% | |
| Aug 31, 2026 FMForm 4 → | Sep 2, 7:58 pm EDT | Jim WassilCHIEF OPERATING OFFICER | 4,955 | $35.83 | $177,542 | 153,609 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 7:57 pm EDT | Grant PickeringCHIEF EXECUTIVE OFFICER, Director | 6,289 | $61.20 | $384,873 | 446,958 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 7:56 pm EDT | Andrew GuggenhimePRESIDENT AND CFO | 2,705 | $61.18 | $165,505 | 102,471 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 7:56 pm EDT | Harpreet S. DhaliwalChief Technical Ops Officer | 1,020 | $61.28 | $62,508 | 75,736 | — | |
| Aug 31, 2026 FForm 4 → | Sep 2, 7:54 pm EDT | Elvia CowanSVP, Finance & CAO | 569 | $61.22 | $34,835 | 29,187 | — | |
| Aug 5, 2026 SForm 4 → | Aug 5, 7:01 pm EDT | Harpreet S. DhaliwalChief Technical Ops Officer | 17,000 | $55.00 | $935,068 | 76,756 | −18.1% | 10b5-1 |
| Aug 5, 2026 MForm 4 → | Aug 5, 7:01 pm EDT | Harpreet S. DhaliwalChief Technical Ops Officer | 17,000 | $24.79 | $421,430 | 93,756 | — | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 4:59 pm EDT | Jim WassilCHIEF OPERATING OFFICER | 2,250 | $53.86 | $121,195 | 157,541 | −1.41% | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 5, 4:59 pm EDT | Jim WassilCHIEF OPERATING OFFICER | 2,250 | $5.35 | $12,038 | 159,791 | — | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 5, 4:58 pm EDT | Andrew GuggenhimePRESIDENT AND CFO | 10,000 | $53.89 | $538,879 | 105,176 | −8.68% | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 5, 4:58 pm EDT | Andrew GuggenhimePRESIDENT AND CFO | 10,000 | $5.35 | $53,500 | 115,176 | — | 10b5-1 |
| Jul 27, 2026 SForm 4 → | Jul 28, 4:10 pm EDT | Grant PickeringCHIEF EXECUTIVE OFFICER, Director | 18,198 | $55.63 | $1,012,375 | 133,215 | −12.0% | 10b5-1 |
| Jul 27, 2026 MForm 4 → | Jul 28, 4:10 pm EDT | Grant PickeringCHIEF EXECUTIVE OFFICER, Director | 16,198 | $2.03 | $32,882 | 469,445 | — | 10b5-1 |
| Jul 6, 2026 SForm 4 → | Jul 6, 7:31 pm EDT | Andrew GuggenhimePRESIDENT AND CFO | 10,000 | $57.28 | $572,837 | 104,395 | −8.74% | 10b5-1 |
| Jul 6, 2026 MForm 4 → | Jul 6, 7:31 pm EDT | Andrew GuggenhimePRESIDENT AND CFO | 10,000 | $5.35 | $53,500 | 114,395 | — | 10b5-1 |
| Jul 1, 2026 SForm 4 → | Jul 6, 6:25 pm EDT | Jim WassilCHIEF OPERATING OFFICER | 2,250 | $56.33 | $126,736 | 156,760 | −1.42% | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 6:25 pm EDT | Jim WassilCHIEF OPERATING OFFICER | 516 | $5.35 | $2,761 | 159,010 | — | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2026 AForm 4 → | Sep 9, 5:40 pm EDT | Luis JodarChief Medical Officer | 88,254 | — | — | 88,254 | — | |
| Sep 1, 2026 MForm 4 → | Sep 2, 7:58 pm EDT | Jim WassilCHIEF OPERATING OFFICER | 2,250 | — | — | 66,648 | — | |
| Aug 5, 2026 MForm 4 → | Aug 5, 7:01 pm EDT | Harpreet S. DhaliwalChief Technical Ops Officer | 17,000 | — | — | 28,000 | — | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 5, 4:59 pm EDT | Jim WassilCHIEF OPERATING OFFICER | 2,250 | — | — | 68,898 | — | 10b5-1 |
| Aug 3, 2026 MForm 4 → | Aug 5, 4:58 pm EDT | Andrew GuggenhimePRESIDENT AND CFO | 10,000 | — | — | 216,827 | — | 10b5-1 |
| Jul 27, 2026 MForm 4 → | Jul 28, 4:10 pm EDT | Grant PickeringCHIEF EXECUTIVE OFFICER, Director | 16,198 | — | — | 137,000 | — | 10b5-1 |
| Jul 16, 2026 AForm 4 → | Jul 16, 4:56 pm EDT | John MarkelsDirector | 23,029 | — | — | 23,029 | — | |
| Jul 6, 2026 MForm 4 → | Jul 6, 7:31 pm EDT | Andrew GuggenhimePRESIDENT AND CFO | 10,000 | — | — | 226,827 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 6, 6:25 pm EDT | Jim WassilCHIEF OPERATING OFFICER | 516 | — | — | 71,148 | — | 10b5-1 |